نتائج البحث - M. V. Faraponova

Optimisation of Approaches to Adverse Event Analysis in Bioequivalence Clinical Trials حسب A. B. Verveda, V. B. Vasilyuk, G. I. Syraeva, M. V. Faraponova

Connect to this object online.

Assessment of the influence of demographic and anthropometric indicators on the variability of pharmacokinetic parameters حسب V. B. Vasilyuk, A. B. Verveda, M. V. Faraponova, G. I. Syraeva

Connect to this object online.

Toxic reactions of non-steroidal anti-inflammatory drugs in the Russian Federation, analysis of the national database "Pharmacovigilance" حسب G. I. Syraeva, V. B. Vasilyuk, A. V. Verveda, M. V. Faraponova, A. S. Kolbin, V. G. Borovskaya

Connect to this object online.

Comparative evaluation of safety parameters at the preclinical and clinical stages of the study of the Reamberin® (LLC "POLYSAN") حسب V. B.  Vasilyuk, M. V. Faraponova, G. I. Syraeva, A. B. Verveda, A. V. Belskaya, A.  V. Shults, L. G. Kubarskaya, E. A. Zolotoverkhaya

Connect to this object online.

Individual features of the pharmacokinetics of fludarabin phosphate in the treatment of patients with chronic lymphocytic leukemia حسب G. G. Rodionov, I. I. Shantyr, V. B. Vasilyuk, E. A. Kolobova, E. V. Svetkina, M. V. Faraponova, A. B. Verveda, G. I. Syraeva, K. A. Zakharov

Connect to this object online.